APD668_SDS_MedChemExpress
磁力架说明书_Magnetic Stand Manual_MCE

1包装清单产品概述MCE 磁力架是磁珠产品专用配套设备,支持 MCE 全线磁珠类产品,内含强磁磁芯,可实现快速高效的分离。
MCE 磁力架 (200 μL / 2 mL / 15 mL ) 采用独特的三明治槽设计,磁条可抽出,可容纳 200 μL PCR 管,1.5 mL EP 管,2 mL EP 管,15 mL 离心管。
本产品适用于抗体纯化、免疫沉淀 (IP )、免疫共沉淀 (Co-IP )、细胞分选和核酸分离等实验。
2操作说明31. 将装有磁珠悬液的 EP 管/离心管置于磁力架对应的样品孔中,静置数分钟后磁珠被吸附聚集于管壁,溶液恢复澄清。
2. 用移液器或吸管从管底将溶液吸出,或小心倾倒出液体。
3. 抽去磁力条,加入复溶液体,轻缓震荡即可混合均匀,进行下一步操作。
注:磁性分离的时间与磁珠粒径有关,磁珠粒径越小,磁性分离时间越长。
此外,溶液的黏稠程度以及溶液的成分也会对磁性分离时间产生影响。
5注意事项1. 根据实验参数和样品体积不同,可调整磁芯位置或选用不同样式的磁力架。
2. 为减少操作过程中磁珠的损失,请将样品管底端插入磁力架底部的凹槽内。
当磁珠吸附在管壁上后,缓慢倾去上清,或用移液枪吸尽。
3. 由于磁力架有强大的磁场,请远离手机、电脑、手表、起博器、磁铁等易被磁力干扰的物体,尤其是刀具,以免对操作人员造成伤害。
4. 如需同时使用多个磁力架 (≥2 个) ,应分开放置,避免磁场之间产生干扰。
不要把多个磁棒放在一起,以防止夹伤。
5. 请勿与强酸、强碱等腐蚀性溶剂直接接触。
6. 请勿拆卸磁块。
7. 为保护外壳,请勿长时间暴露在阳光和紫外线下。
8. 为保持磁力架磁性,请勿置于高温和强外界磁场环境中。
9. 使用后请及时清洁,妥善放置在干燥环境中。
Magnetic StandMedChemExpress MedChemExpress 400-820-3792 电话: ************ 传真: ************Email: t *********************MCE Hotline: 400-820-3792Contents HY-K0200Magnetic Stand 200 μL-2 mL-15 mL。
SDS—聚丙烯酰胺垂直平板电泳

14,900
图2:蛋白质分子量标准曲线
SDS-聚丙烯酰胺凝胶电泳低分子量蛋白质标准曲线图 5.2 5 4.8 y = -0.1832x + 5.2079 2 R = 0.9802
Log MW
4.6 4.4 4.2 4 0 2 4 蛋白质迁移率(MW) 6 8
特别提醒
一定要给出文字性的结果
求职应注意的礼仪
道尔顿 道尔顿 道尔顿
道尔顿
道尔顿
• 鸡蛋清溶菌酶;Hen Egg White Lysozyme
•
MW:14,400 道尔顿
4-2、试剂配制
• • • • • • • • • (1)、电极缓冲液的配制: (2)、丙烯酰胺(Arc) 和甲叉双丙烯酰胺(Bis)溶液的配制: (3)、10%十二烷基硫酸钠(SDS )溶液的配制: (4)、10%过硫酸铵(AP)溶液的配制: (5)、pH8.8;1.5 mol/L三羟甲基氨基甲烷—HC1 Buffer的配制 (6)、pH6.8 ;1.0 mol/L Tris—HC1 Buffer的配制: (7)、四甲基乙二胺(TEMED),直接取原液。 (8)、2%琼脂糖溶液的配制: (用于封电泳槽渗漏) (9)、0.05%溴酚兰溶液的配制: (10)、样品溶液的配制:0.5 mg/1.0ml (11)、标准品溶液的配制: (12)、染色液的配制:
XMD8-87_DataSheet_MedChemExpress

Inhibitors, Agonists, Screening Libraries Data SheetBIOLOGICAL ACTIVITY:XMD8–87 is a potent TNK2 inhibitor with IC 50 values of 38 and 113 nM for the D163E and R806Q mutations, respectively.IC50 & Target: IC50: 38 nM (TNK2, D163E mutation), 113 nM (TNK2, R806Q mutation)[1]In Vitro: XMD8–87 potently inhibits the growth of the TNK2 mutant expressing cell lines while having little or no effect on the control cells out to the highest tested concentrations (1,000 nM). XMD8–87 has IC 50s of 38 nM and 113 nM for the D163E and R806Q mutations. The effects of XMD8–87 on TNK2 cell lines are largely due to on–target effects on TNK2. Auto–phosphorylation of overexpressed TNK2 mutants could be blocked with TNK2 inhibitor XMD8–87[1].PROTOCOL (Extracted from published papers and Only for reference)Kinase Assay:[1]Kinase targets are tested with biochemical enzymatic kinase assays using the SelectScreen Kinase Profiling Service to determine IC 50 values. The compounds (XMD8–87) are assayed at 10 concentrations (3–fold serial dilutions starting from 1 μM) at an ATP concentration equal to the ATP Km [1].Cell Assay:[1]Cells are treated with the following inhibitors for 72 hours: dasatinib, AIM–100, XMD8–87 and XMD16–5. Cell viability is measured using a methanethiosulfonate (MTS)–based assay and absorbance (490 nm) is read at 1 and 3 hours after adding reagent [1].References:[1]. Maxson JE, et al. Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis.Product Name:XMD8–87Cat. No.:HY-15811CAS No.:1234480-46-6Molecular Formula:C 24H 27N 7O 2Molecular Weight:445.52Target:Tyrosinase Pathway:Metabolic Enzyme/Protease Solubility:DMSO: ≥ 26 mg/mLCaution: Product has not been fully validated for medical applications. For research use only.Tel: 609-228-6898 Fax: 609-228-5909 E-mail: tech@ Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA。
药剂学(崔福德主编_第七版)

药剂学常考试题集锦一、名词解释1.Critical micelle concentration (CMC):临界胶束浓度,表面活性剂分子缔合形成胶束的最低浓度即为临界胶束浓度。
(A卷考题)P372.Krafft point:即克拉夫特点,离子型表面活性剂在温度较低时溶解度很小,但随温度升高而逐渐增加,当到达某一特定温度时,溶解度急剧陡升,把该温度称为克拉夫特点。
(A卷考题)P413. cloud poing: 即昙点,也称为浊点,某些含聚氧乙烯基的非离子表面活性剂的溶解度开始随温度上升而加大,到某一温度后其溶解度急剧下降,使溶液变混浊,甚至产生分层,但冷后又可恢复澄明。
这种由澄明变混浊的现象称为起昙,这个转变温度称为昙点。
(B卷考题)P424.助溶:系指难溶性药物与加入的第三种物质在溶剂中形成可溶性分子络合物、复盐或分子缔合物等,以增加药物在溶剂中溶解度的过程。
(A卷和B卷考题)5、脂质体:是指将药物包封于类脂质双分子层形成的薄膜中间所制成的超微型球状体,是一种类似微型胶囊的新剂型。
(B卷考题)6.碘值:脂肪不饱和程度的一种度量,等于100g脂肪所摄取碘的克数。
检测时,以淀粉液作指示剂,用标准硫代硫酸钠液进行滴定。
碘值大说明油脂中不饱和脂肪酸含量高或其不饱和程度高。
7. 酸值:酸值又称酸价。
是指中和1g天然脂肪中的游离酸所需消耗氢氧化钾的毫克数。
酸值的大小反映了脂肪中游离酸含量的多少。
P1948.Pyrogen: 热原,是微生物的代谢产物。
热原=内毒素=脂多糖。
9.增溶10. 置换价11. F0值12. Prodrug:前体药物,也称前药、药物前体、前驅藥物等,是指经过生物体内转化后才具有药理作用的化合物。
前体药物本身没有生物活性或活性很低,经过体内代谢后变为有活性的物质,这一过程的目的在于增加药物的生物利用度,加强靶向性,降低药物的毒性和副作用。
目前前体药物分为两大类:载体前体药物(carrier-prodrug)和生物前体(bioprecursor)。
Presatovir产品说明书

1. PRODUCT AND COMPANY IDENTIFICATION1.1 Product identifierProduct name :Presatovir Catalog No. :HY-16727CAS No. :1353625-73-61.2 Relevant identified uses of the substance or mixture and uses advised against Identified uses :Laboratory chemicals, manufacture of substances.1.3 Details of the supplier of the safety data sheetCompany:MedChemExpress USA Tel:609-228-6898Fax:609-228-5909E-mail:1.4 Emergency telephone numberEmergency Phone #:609-228-68982. HAZARDS IDENTIFICATION2.1 Classification of the substance or mixtureNot a hazardous substance or mixture.2.2 GHS Label elements, including precautionary statementsNot a hazardous substance or mixture.2.3 Other hazardsNone.3. COMPOSITION/INFORMATION ON INGREDIENTS3.1 SubstancesSynonyms:GS-5806Formula:C 24H 30ClN 7O 3S Molecular Weight:532.06CAS No. :1353625-73-64. FIRST AID MEASURES4.1 Description of first aid measuresEye contactRemove any contact lenses, locate eye-wash station, and flush eyes immediately with large amounts of water. Separate eyelids with fingers to ensure adequate flushing. Promptly call a physician. Skin contactSafety Data SheetRevision Date:Jun.-3-2021Print Date:Feb.-17-2023Inhibitors •Screening Libraries•ProteinsRinse skin thoroughly with large amounts of water. Remove contaminated clothing and shoes and call a physician.InhalationImmediately relocate self or casualty to fresh air. If breathing is difficult, give cardiopulmonary resuscitation (CPR). Avoid mouth-to-mouth resuscitation.IngestionWash out mouth with water; Do NOT induce vomiting; call a physician.4.2 Most important symptoms and effects, both acute and delayedThe most important known symptoms and effects are described in the labelling (see section 2.2).4.3 Indication of any immediate medical attention and special treatment neededTreat symptomatically.5. FIRE FIGHTING MEASURES5.1 Extinguishing mediaSuitable extinguishing mediaUse water spray, dry chemical, foam, and carbon dioxide fire extinguisher.5.2 Special hazards arising from the substance or mixtureDuring combustion, may emit irritant fumes.5.3 Advice for firefightersWear self-contained breathing apparatus and protective clothing.6. ACCIDENTAL RELEASE MEASURES6.1 Personal precautions, protective equipment and emergency proceduresUse full personal protective equipment. Avoid breathing vapors, mist, dust or gas. Ensure adequate ventilation. Evacuate personnel to safe areas.Refer to protective measures listed in sections 8.6.2 Environmental precautionsTry to prevent further leakage or spillage. Keep the product away from drains or water courses.6.3 Methods and materials for containment and cleaning upAbsorb solutions with finely-powdered liquid-binding material (diatomite, universal binders); Decontaminate surfaces and equipment by scrubbing with alcohol; Dispose of contaminated material according to Section 13.7. HANDLING AND STORAGE7.1 Precautions for safe handlingAvoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust ventilation.7.2 Conditions for safe storage, including any incompatibilitiesKeep container tightly sealed in cool, well-ventilated area. Keep away from direct sunlight and sources of ignition.Recommended storage temperature:Powder-20°C 3 years4°C 2 yearsIn solvent-80°C 6 months-20°C 1 monthShipping at room temperature if less than 2 weeks.7.3 Specific end use(s)No data available.8. EXPOSURE CONTROLS/PERSONAL PROTECTION8.1 Control parametersComponents with workplace control parametersThis product contains no substances with occupational exposure limit values.8.2 Exposure controlsEngineering controlsEnsure adequate ventilation. Provide accessible safety shower and eye wash station.Personal protective equipmentEye protection Safety goggles with side-shields.Hand protection Protective gloves.Skin and body protection Impervious clothing.Respiratory protection Suitable respirator.Environmental exposure controls Keep the product away from drains, water courses or the soil. Cleanspillages in a safe way as soon as possible.9. PHYSICAL AND CHEMICAL PROPERTIES9.1 Information on basic physical and chemical propertiesAppearance SolidOdor No data availableOdor threshold No data availablepH No data availableMelting/freezing point No data availableBoiling point/range No data availableFlash point No data availableEvaporation rate No data availableFlammability (solid, gas)No data availableUpper/lower flammability or explosive limits No data availableVapor pressure No data availableVapor density No data availableRelative density No data availableWater Solubility No data availablePartition coefficient No data availableAuto-ignition temperature No data availableDecomposition temperature No data availableViscosity No data availableExplosive properties No data availableOxidizing properties No data available9.2 Other safety informationNo data available.10. STABILITY AND REACTIVITY10.1 ReactivityNo data available.10.2 Chemical stabilityStable under recommended storage conditions.10.3 Possibility of hazardous reactionsNo data available.10.4 Conditions to avoidNo data available.10.5 Incompatible materialsStrong acids/alkalis, strong oxidising/reducing agents.10.6 Hazardous decomposition productsUnder fire conditions, may decompose and emit toxic fumes.Other decomposition products - no data available.11.TOXICOLOGICAL INFORMATION11.1 Information on toxicological effectsAcute toxicityClassified based on available data. For more details, see section 2Skin corrosion/irritationClassified based on available data. For more details, see section 2Serious eye damage/irritationClassified based on available data. For more details, see section 2Respiratory or skin sensitizationClassified based on available data. For more details, see section 2Germ cell mutagenicityClassified based on available data. For more details, see section 2CarcinogenicityIARC: No component of this product present at a level equal to or greater than 0.1% is identified as probable, possible or confirmed human carcinogen by IARC.ACGIH: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by ACGIH.NTP: No component of this product present at a level equal to or greater than 0.1% is identified as a anticipated or confirmed carcinogen by NTP.OSHA: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by OSHA.Reproductive toxicityClassified based on available data. For more details, see section 2Specific target organ toxicity - single exposureClassified based on available data. For more details, see section 2Specific target organ toxicity - repeated exposureClassified based on available data. For more details, see section 2Aspiration hazardClassified based on available data. For more details, see section 2Additional informationThis information is based on our current knowledge. However the chemical, physical, and toxicological properties have not been completely investigated.12. ECOLOGICAL INFORMATION12.1 ToxicityNo data available.12.2 Persistence and degradabilityNo data available.12.3 Bioaccumlative potentialNo data available.12.4 Mobility in soilNo data available.12.5 Results of PBT and vPvB assessmentPBT/vPvB assessment unavailable as chemical safety assessment not required or not conducted.12.6 Other adverse effectsNo data available.13. DISPOSAL CONSIDERATIONS13.1 Waste treatment methodsProductDispose substance in accordance with prevailing country, federal, state and local regulations.Contaminated packagingConduct recycling or disposal in accordance with prevailing country, federal, state and local regulations.14. TRANSPORT INFORMATIONDOT (US)Proper shipping name: Not dangerous goodsUN number: -Class: -Packing group: -IMDGProper shipping name: Not dangerous goodsUN number: -Class: -Packing group: -IATAProper shipping name: Not dangerous goodsUN number: -Class: -Packing group: -15. REGULATORY INFORMATIONSARA 302 Components:No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.SARA 313 Components:This material does not contain any chemical components with known CAS numbers that exceed the threshold (De Minimis) reporting levels established by SARA Title III, Section 313.SARA 311/312 Hazards:No SARA Hazards.Massachusetts Right To Know Components:No components are subject to the Massachusetts Right to Know Act.Pennsylvania Right To Know Components:No components are subject to the Pennsylvania Right to Know Act.New Jersey Right To Know Components:No components are subject to the New Jersey Right to Know Act.California Prop. 65 Components:This product does not contain any chemicals known to State of California to cause cancer, birth defects, or anyother reproductive harm.16. OTHER INFORMATIONCopyright 2023 MedChemExpress. The above information is correct to the best of our present knowledge but does not purport to be all inclusive and should be used only as a guide. The product is for research use only and for experienced personnel. It must only be handled by suitably qualified experienced scientists in appropriately equipped and authorized facilities. The burden of safe use of this material rests entirely with the user. MedChemExpress disclaims all liability for any damage resulting from handling or from contact with this product.Caution: Product has not been fully validated for medical applications. For research use only.Tel:609-228-6898Fax:609-228-5909E-mail:***********************Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA。
超声波辅助SDS反胶束前萃花生蛋白研究

c p y lo o t o iain Th fe t fa dn mo n fp a u o e ,p , xrcin t e a r l c h lwi s n c t . ee fcso d iga u to e n t wd r H e ta t i , a h o p o m
p we 7 , C n e t t n02 lL, e o cn a o f DSO0 / o r 0 K 1 o cnr i . mo/ t n et t no . g mL, tr o t t Wo) 2 W c ao 5 hc r i S 7 wa ne ( ec n
e ta t n p o e s t er s l h we a eo t m o d t n ff r r x r ci n we e a d n x ci r c s , h e u t s o d t t h p i r o s h t mu c n i o s o wa d e t t r : d i g i o a o
adtmp rtr , e lao i p we, 1 o cn a o , e o c nrt no DS wa r o t t Wo) n e eauet t snc o rKC n et t n t n e t i f hur c r i hc ao S , t ne ( ec n
辅 助 非离子 表 面活性 剂 ( ro - O 反胶 团后 萃 T i nX I0) t
一种抗肝素干扰的C反应蛋白检测试剂盒[发明专利]
![一种抗肝素干扰的C反应蛋白检测试剂盒[发明专利]](https://img.taocdn.com/s3/m/9be01b3a76a20029bc642d4c.png)
专利名称:一种抗肝素干扰的C反应蛋白检测试剂盒专利类型:发明专利
发明人:邵丹,赵民,王美丽
申请号:CN201811111054.X
申请日:20180922
公开号:CN109297919A
公开日:
20190201
专利内容由知识产权出版社提供
摘要:本发明涉及临床体外检测试剂技术领域,特别涉及一种抗肝素干扰的C反应蛋白检测试剂盒。
本发明试剂盒是双试剂液体型试剂盒,试剂R1包括乙二胺四乙酸二钠、磷酸氢二钠、磷酸二氢钾、氯化钠、聚乙二醇,试剂R2包括乙二胺四乙酸二钠、磷酸氢二钠、磷酸二氢钾、氯化钠、聚乙二醇、CRP抗体。
本发明试剂组分中聚乙二醇6000投料减少,可解决肝素干扰问题,具有很好的市场潜力。
申请人:山东博科生物产业有限公司
地址:250200 山东省济南市章丘区明水经济开发区(经十东路与明埠路交界山东博科产业园)国籍:CN
更多信息请下载全文后查看。
氯化苯丙胺盐法全自动化检测微量总蛋白存在重大的方法学缺陷

氯化苯丙胺盐法全自动化检测微量总蛋白存在重大的方法学缺陷庄小青;罗士来;杨露;夏前凤;薛梦【期刊名称】《国际检验医学杂志》【年(卷),期】2016(000)002【摘要】目的:探讨氯化苯丙胺盐法全自动化检测脑脊液或尿液中微量总蛋白发生严重差错的原因。
方法将定值总蛋白采用连续递减稀释法获得35例标本(总蛋白质量浓度0~30 g/L ),然后在贝克曼DXC800生化分析仪上采用氯化苯丙胺盐法检测。
结果(1)当总蛋白质量浓度为0~3 g/L时检测值呈线性增加,与理论值一致。
(2)当总蛋白质量浓度为3~9 g/L时检测值递减,在0.5~2.5g/L之间。
当总蛋白质量浓度大于9g/L时检测值趋于0.5g/L左右。
结论该法不能满足全自动化检测的单区间要求,即检测值存在二元性,故不宜单独采用全自动生化分析仪检测。
【总页数】3页(P275-276,277)【作者】庄小青;罗士来;杨露;夏前凤;薛梦【作者单位】泗阳仁慈医院检验科,江苏宿迁223700;泗阳县中医院检验科,江苏宿迁223700;泗阳仁慈医院检验科,江苏宿迁223700;泗阳县中医院检验科,江苏宿迁223700;泗阳县中医院检验科,江苏宿迁223700【正文语种】中文【相关文献】1.氯化苯丙胺盐比浊法检测脑脊液蛋白质方法学评价 [J], 唐晓霞2.微量双缩脲比色法测定脑脊液总蛋白的方法学研究 [J], 任治国3.氯化苯松宁微量脑脊液总蛋白测定法 [J], 陆迪生4.ICP-MS测定全血8种微量元素的方法学建立与性能评价 [J], 张亚梅;高静5.全基因表达分析标准方法存在重大缺陷 [J],因版权原因,仅展示原文概要,查看原文内容请购买。
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
Inhibitors, Agonists, Screening LibrariesSafety Data Sheet Revision Date:Jul.-18-2017Print Date:Jul.-18-20171. PRODUCT AND COMPANY IDENTIFICATION1.1 Product identifierProduct name :APD668Catalog No. :HY-15565CAS No. :832714-46-21.2 Relevant identified uses of the substance or mixture and uses advised againstIdentified uses :Laboratory chemicals, manufacture of substances.1.3 Details of the supplier of the safety data sheetCompany:MedChemExpress USATel:609-228-6898Fax:609-228-5909E-mail:sales@1.4 Emergency telephone numberEmergency Phone #:609-228-68982. HAZARDS IDENTIFICATION2.1 Classification of the substance or mixtureNot a hazardous substance or mixture.2.2 GHS Label elements, including precautionary statementsNot a hazardous substance or mixture.2.3 Other hazardsNone.3. COMPOSITION/INFORMATION ON INGREDIENTS3.1 SubstancesSynonyms:APD 668; APD–668Formula:C21H24FN5O5SMolecular Weight:477.51CAS No. :832714-46-24. FIRST AID MEASURES4.1 Description of first aid measuresEye contactRemove any contact lenses, locate eye-wash station, and flush eyes immediately with large amounts of water. Separate eyelids with fingers to ensure adequate flushing. Promptly call a physician.Skin contactRinse skin thoroughly with large amounts of water. Remove contaminated clothing and shoes and call a physician.InhalationImmediately relocate self or casualty to fresh air. If breathing is difficult, give cardiopulmonary resuscitation (CPR). Avoid mouth-to-mouth resuscitation.IngestionWash out mouth with water; Do NOT induce vomiting; call a physician.4.2 Most important symptoms and effects, both acute and delayedThe most important known symptoms and effects are described in the labelling (see section 2.2).4.3 Indication of any immediate medical attention and special treatment neededTreat symptomatically.5. FIRE FIGHTING MEASURES5.1 Extinguishing mediaSuitable extinguishing mediaUse water spray, dry chemical, foam, and carbon dioxide fire extinguisher.5.2 Special hazards arising from the substance or mixtureDuring combustion, may emit irritant fumes.5.3 Advice for firefightersWear self-contained breathing apparatus and protective clothing.6. ACCIDENTAL RELEASE MEASURES6.1 Personal precautions, protective equipment and emergency proceduresUse full personal protective equipment. Avoid breathing vapors, mist, dust or gas. Ensure adequate ventilation. Evacuate personnel to safe areas.Refer to protective measures listed in sections 8.6.2 Environmental precautionsTry to prevent further leakage or spillage. Keep the product away from drains or water courses.6.3 Methods and materials for containment and cleaning upAbsorb solutions with finely-powdered liquid-binding material (diatomite, universal binders); Decontaminate surfaces and equipment by scrubbing with alcohol; Dispose of contaminated material according to Section 13.7. HANDLING AND STORAGE7.1 Precautions for safe handlingAvoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust ventilation.7.2 Conditions for safe storage, including any incompatibilitiesKeep container tightly sealed in cool, well-ventilated area. Keep away from direct sunlight and sources of ignition.Recommended storage temperature:Powder-20°C 3 years4°C 2 yearsIn solvent-80°C 6 months-20°C 1 monthShipping at room temperature if less than 2 weeks.7.3 Specific end use(s)No data available.8. EXPOSURE CONTROLS/PERSONAL PROTECTION8.1 Control parametersComponents with workplace control parametersThis product contains no substances with occupational exposure limit values.8.2 Exposure controlsEngineering controlsEnsure adequate ventilation. Provide accessible safety shower and eye wash station.Personal protective equipmentEye protection Safety goggles with side-shields.Hand protection Protective gloves.Skin and body protection Impervious clothing.Respiratory protection Suitable respirator.Environmental exposure controls Keep the product away from drains, water courses or the soil. Cleanspillages in a safe way as soon as possible.9. PHYSICAL AND CHEMICAL PROPERTIES9.1 Information on basic physical and chemical propertiesAppearance White to off-white (Solid)Odor No data availableOdor threshold No data availablepH No data availableMelting/freezing point No data availableBoiling point/range No data availableFlash point No data availableEvaporation rate No data availableFlammability (solid, gas)No data availableUpper/lower flammability or explosive limits No data availableVapor pressure No data availableVapor density No data availableRelative density No data availableWater Solubility No data availablePartition coefficient No data availableAuto-ignition temperature No data availableDecomposition temperature No data availableViscosity No data availableExplosive properties No data availableOxidizing properties No data available9.2 Other safety informationNo data available.10. STABILITY AND REACTIVITY10.1 ReactivityNo data available.10.2 Chemical stabilityStable under recommended storage conditions.10.3 Possibility of hazardous reactionsNo data available.10.4 Conditions to avoidNo data available.10.5 Incompatible materialsStrong acids/alkalis, strong oxidising/reducing agents.10.6 Hazardous decomposition productsUnder fire conditions, may decompose and emit toxic fumes.Other decomposition products - no data available.11.TOXICOLOGICAL INFORMATION11.1 Information on toxicological effectsAcute toxicityClassified based on available data. For more details, see section 2Skin corrosion/irritationClassified based on available data. For more details, see section 2Serious eye damage/irritationClassified based on available data. For more details, see section 2Respiratory or skin sensitizationClassified based on available data. For more details, see section 2Germ cell mutagenicityClassified based on available data. For more details, see section 2CarcinogenicityIARC: No component of this product present at a level equal to or greater than 0.1% is identified as probable, possible or confirmed human carcinogen by IARC.ACGIH: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by ACGIH.NTP: No component of this product present at a level equal to or greater than 0.1% is identified as a anticipated or confirmed carcinogen by NTP.OSHA: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by OSHA.Reproductive toxicityClassified based on available data. For more details, see section 2Specific target organ toxicity - single exposureClassified based on available data. For more details, see section 2Specific target organ toxicity - repeated exposureClassified based on available data. For more details, see section 2Aspiration hazardClassified based on available data. For more details, see section 212. ECOLOGICAL INFORMATION12.1 ToxicityNo data available.12.2 Persistence and degradabilityNo data available.12.3 Bioaccumlative potentialNo data available.12.4 Mobility in soilNo data available.12.5 Results of PBT and vPvB assessmentPBT/vPvB assessment unavailable as chemical safety assessment not required or not conducted.12.6 Other adverse effectsNo data available.13. DISPOSAL CONSIDERATIONS13.1 Waste treatment methodsProductDispose substance in accordance with prevailing country, federal, state and local regulations.Contaminated packagingConduct recycling or disposal in accordance with prevailing country, federal, state and local regulations.14. TRANSPORT INFORMATIONDOT (US)This substance is considered to be non-hazardous for transport.IMDGThis substance is considered to be non-hazardous for transport.IATAThis substance is considered to be non-hazardous for transport.15. REGULATORY INFORMATIONSARA 302 Components:No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.SARA 313 Components:This material does not contain any chemical components with known CAS numbers that exceed the threshold (De Minimis) reporting levels established by SARA Title III, Section 313.SARA 311/312 Hazards:No SARA Hazards.Massachusetts Right To Know Components:No components are subject to the Massachusetts Right to Know Act.Pennsylvania Right To Know Components:No components are subject to the Pennsylvania Right to Know Act.New Jersey Right To Know Components:No components are subject to the New Jersey Right to Know Act.California Prop. 65 Components:This product does not contain any chemicals known to State of California to cause cancer, birth defects, or anyother reproductive harm.16. OTHER INFORMATIONCopyright 2017 MedChemExpress. The above information is correct to the best of our present knowledge but does not purport to be all inclusive and should be used only as a guide. The product is for research use only and for experienced personnel. It must only be handled by suitably qualified experienced scientists in appropriately equipped and authorized facilities. The burden of safe use of this material rests entirely with the user. MedChemExpress disclaims all liability for any damage resulting from handling or from contact with this product.Caution: Product has not been fully validated for medical applications. For research use only.Tel: 609-228-6898 Fax: 609-228-5909 E-mail: tech@Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA。